Clinical efficacy and predictive molecular markers of neoadjuvant gemcitabine and pemetrexed in resectable non-small cell lung cancer.
Bepler G, Sommers KE, Cantor A, Li X, Sharma A, Williams C, Chiappori A, Haura E, Antonia S, Tanvetyanon T, Simon G, Obasaju C, Robinson LA.
J Thorac Oncol. 2008 Oct;3(10):1112-8.PMID: 18827606 [PubMed - indexed for MEDLINE]Related articlesFree article